强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JNJ 强生

休市中 04-10 16:00:00 EDT

238.46

-2.85

-1.18%

盘后238.94

+0.47+0.20%

19:55 EDT

最高242.26	最低237.91	成交量735.45万
今开242.00	昨收241.31	日振幅1.80%
总市值5,745亿	流通市值5,734亿	总股本24.09亿
成交额17.56亿	换手率0.31%	流通股本24.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":238.46,"timestamp":1775851200000,"preClose":241.31,"halted":0,"volume":7354528,"hourTrading":{"tag":"盘后","latestPrice":238.935,"preClose":238.46,"latestTime":"19:55 EDT","volume":756910,"amount":180491159.1022,"timestamp":1775865327790,"change":0.475,"changeRate":0.001992,"amplitude":0.005147},"delay":0,"changeRate":-0.011810534167668122,"floatShares":2404573193,"shares":2409295102,"eps":11.03,"marketStatus":"休市中","change":-2.85,"latestTime":"04-10 16:00:00 EDT","open":242,"high":242.26,"low":237.91,"amount":1756410362.68256,"amplitude":0.018027,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":11.03,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":241.31,"dividendRate":0.021555,"preHourTrading":{"tag":"盘前","latestPrice":241.46,"preClose":241.31,"latestTime":"09:28 EDT","volume":4185,"amount":1011980.08125,"timestamp":1775827685782,"change":0.15,"changeRate":0.000622,"amplitude":0.01086},"postHourTrading":{"tag":"盘后","latestPrice":238.935,"preClose":238.46,"latestTime":"19:55 EDT","volume":756910,"amount":180491159.1022,"timestamp":1775865327790,"change":0.475,"changeRate":0.001992,"amplitude":0.005147},"volumeRatio":1.1362323763147453,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":false,"expireDate":1776398400000,"strike":"240.0","timestamp":1775839538941,"price":4.8,"volume":2500,"amount":1200000,"type":"*"}]},"impliedVol":0.2682,"impliedVolPercentile":0.88},"requestUrl":"/m/hq/s/JNJ/wiki","defaultTab":"wiki","newsList":[{"id":"1184072442","title":"强生欧洲推出Varipulse Pro，推进脉冲电场消融产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1184072442","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184072442?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:01","pubTimestamp":1775563303,"startTime":"0","endTime":"0","summary":"强生公司通过在欧洲市场推出Varipulse Pro产品，进一步拓展了其脉冲电场消融技术产品线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0001KFT4U8.USD","LU0795875086.SGD","IE00BN8TJ469.HKD","LU0320765646.SGD","LU1057294990.SGD","LU1061106388.HKD","BK4568","SG9999002224.SGD","LU0795875169.SGD","LU1430594728.SGD","IE00B3PB1722.GBP","IE0009355771.USD","IE00BGHQF631.EUR","IE0034235303.USD","LU0889566641.SGD","LU2505996681.GBP","LU2471134796.USD","LU0683600562.USD","IE000M9KFDE8.USD","LU1066051811.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0058720904.USD","LU1585245621.USD","IE00BBT3K403.USD","BK4504","LU2468319806.SGD","LU1162221912.USD","LU2129689431.USD","LU1032955483.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1059921491.USD","BK4534","LU2112291526.USD","LU2430703095.HKD","IE000BZT7R73.USD","LU2602419157.SGD","LU1983299246.USD","LU0345770993.USD","LU2505996509.AUD","BK4559","LU2471134879.HKD","IE000SO60NU8.SGD","IE000MB6IJN5.SGD","LU1221951129.SGD","LU0640476718.USD","BK4533","BK4581","LU1066053197.SGD","LU1778281490.HKD","IE0002270589.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2133065610.SGD","LU0994945656.USD","SG9999002232.USD","LU2347655156.SGD","IE000WAW04H5.SGD","IE00BLSP4239.USD","IE00BVYPNV92.GBP","LU1894683264.USD","LU1935042991.SGD","LU1066051498.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU1066051225.USD","IE0000B7K699.USD","LU0114720955.EUR","LU1674673691.USD","LU0122379950.USD","LU1732799900.SGD","LU1267930813.SGD","IE00B19Z3B42.SGD","LU2129689605.HKD","LU0345769631.USD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","LU0203345920.USD","IE00BFXG1179.USD","LU0466842654.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU1121112475.USD","LU2089984988.USD","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU0426417589.USD","LU0234572021.USD","LU1043141396.HKD","LU2129689514.USD","LU0912757837.SGD","LU0882574055.USD","LU1196500208.SGD","LU1280957306.USD","LU1894683348.USD","LU0426412945.USD","LU0345770308.USD","LU1718418525.SGD","BK4532","IE000F7OJYX1.SGD","BK4550","LU0787776722.HKD","LU0792757196.USD","SG9999001440.SGD","LU0345769128.USD","IE00B7SZLL34.SGD","LU1043141123.HKD","BK4007","LU0070217475.USD","LU1674673428.USD","IE00B3T34201.USD","LU2750360641.GBP","LU1074936037.SGD","LU2471134952.CNY","LU1244550221.USD","LU1914381329.SGD","IE00B1BXHZ80.USD","LU1929549753.HKD","LU1244550494.USD","BK4588","IE00BVYPNW00.USD","LU1221951046.USD","LU2430703178.SGD","LU2471134523.USD","LU0289739699.SGD","LU1023059063.AUD","LU0985320562.USD","LU2750360997.AUD","LU0689626769.HKD","LU1506573853.SGD","LU0098860793.USD","LU0124676726.USD","LU0203347892.USD","JNJ","LU1732800096.USD","LU1032466523.USD","LU2430703251.USD","IE00BLSP4452.SGD","BK4585","BK4592","LU1496350502.SGD","LU1244550577.SGD","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197066810","title":"财报前瞻｜强生本季度营收预计增9.58%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1197066810","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197066810?lang=zh_cn&edition=full","pubTime":"2026-04-07 08:04","pubTimestamp":1775520278,"startTime":"0","endTime":"0","summary":"强生将于2026年04月14日美股盘前发布财报，市场聚焦创新药放量与医疗技术延续增长对营收与盈利的拉动效应。上季度公司营收为245.64亿美元，同比增长9.08%；毛利率为68.20%；归属于母公司股东的净利润为51.16亿美元，净利率为20.83%；调整后每股收益为2.46美元，同比增长20.59%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜强生本季度营收预计增9.58%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118549304","title":"Inlexzo™（吉西他滨膀胱灌注系统）获永久计费代码，助力特定膀胱癌患者获取治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1118549304","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118549304?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:51","pubTimestamp":1775062274,"startTime":"0","endTime":"0","summary":"Inlexzo™（吉西他滨膀胱灌注系统）近日被授予永久性计费代码，这一关键进展将为特定类型的膀胱癌患者拓宽治疗可及性。永久代码的落地不仅简化了报销流程，更标志着该创新疗法在临床应用与保险覆盖层面获得制度化认可。医疗系统对精准化膀胱癌解决方案的需求日益增长，此次编码确立有望加速药物普及，让更多患者受益于前沿治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU1894683264.USD","IE00BJJMRZ35.SGD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2112291526.USD","LU2471134796.USD","LU1066053197.SGD","IE00BLSP4239.USD","IE00BVYPNW00.USD","LU1066051811.HKD","LU0985320562.USD","LU0994945656.USD","LU0289739699.SGD","LU0882574055.USD","IE00BBT3K403.USD","LU0912757837.SGD","BK4534","LU2347655156.SGD","IE00B3PB1722.GBP","BK4007","LU2471134879.HKD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU2129689514.USD","BK4588","IE00B2B36J28.USD","LU1066051498.USD","LU1244550494.USD","LU0426412945.USD","IE00B7SZLL34.SGD","LU1032466523.USD","IE0001KFT4U8.USD","IE0002141913.USD","IE00BZ1G4Q59.USD","LU1059921491.USD","LU1929549753.HKD","LU0203345920.USD","BK4550","BK4592","LU0787776722.HKD","IE0034235303.USD","LU0345770308.USD","LU1496350502.SGD","LU2750360997.AUD","LU1196500208.SGD","LU0058720904.USD","LU2430703251.USD","IE00BDGV0183.EUR","LU0795875086.SGD","BK4533","LU1894683348.USD","JNJ","LU0683600562.USD","IE00B42XCP33.USD","BK4585","LU1074936037.SGD","LU2750360641.GBP","LU1121112475.USD","IE00BFXG1179.USD","LU0466842654.USD","LU0426417589.USD","LU0234570918.USD","LU2592432038.USD","LU0098860793.USD","LU2129689605.HKD","IE00B4R5TH58.HKD","LU0345770993.USD","LU1057294990.SGD","BK4568","LU1935042991.SGD","LU0689626769.HKD","LU1506573853.SGD","LU2129689431.USD","LU0122379950.USD","SG9999002232.USD","BK4504","LU0792757196.USD","LU1043141396.HKD","LU1914381329.SGD","LU1983299246.USD","IE000M9KFDE8.USD","BK4559","LU1023059063.AUD","LU1280957306.USD","LU0432979614.USD","LU2468319806.SGD","IE0002270589.USD","LU2505996681.GBP","LU1221951129.SGD","IE00BN8TJ469.HKD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","BK4581","LU0889566641.SGD","LU0203347892.USD","SG9999002224.SGD","LU2505996509.AUD","LU2430703095.HKD","LU1674673691.USD","IE00BKVL7J92.USD","LU1032955483.USD","LU1244550577.SGD","BK4532","LU0114720955.EUR","LU0795875169.SGD","LU2133065610.SGD","IE00B3T34201.USD","LU0345769631.USD","LU1043141123.HKD","LU1732799900.SGD","SG9999001440.SGD","LU1778281490.HKD","LU1061106388.HKD","LU2471134952.CNY","LU0640476718.USD","LU0345769128.USD","LU0070217475.USD","LU1066051225.USD","LU2602419157.SGD","LU2471134523.USD","LU2430703178.SGD","LU1221951046.USD","LU1718418525.SGD","LU1732800096.USD","IE00B1BXHZ80.USD","LU0234572021.USD","LU1162221912.USD","LU0124676726.USD","LU1267930813.SGD","IE00BSNM7G36.USD","IE00BLSP4452.SGD","LU1244550221.USD","LU1261432733.SGD","IE0009355771.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624519326","title":"强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2624519326","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624519326?lang=zh_cn&edition=full","pubTime":"2026-04-01 21:08","pubTimestamp":1775048929,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月31日，中国国家药监局药品审评中心官网公示显示，强生申报的1类新药JNJ-88549968注射液获批临床，拟开发治疗骨髓增殖性肿瘤。本次该产品在中国获批临床，意味着其即将开展针对骨髓增殖性肿瘤的临床研究。据了解，JNJ-88549968是一种靶向CALRmut的T细胞重定向双特异性抗体，其通过清除MPN克隆发挥作用。研究人员认为，该产品有望研发成为用于治疗CALRmut MPN的新型双特异性T细胞重定向抗体。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"强生(JNJ.US)1类新药在华获批临床 拟开发治疗骨髓增殖性肿瘤","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1221951046.USD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","IE0034235303.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU2133065610.SGD","LU0795875086.SGD","LU1280957306.USD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU2129689514.USD","LU1732800096.USD","LU1894683348.USD","LU0114720955.EUR","JNJ","BK4550","BK4533","BK4559","LU1196500208.SGD","LU1983299246.USD","IE0001KFT4U8.USD","LU1894683264.USD","BK4532","LU0792757196.USD","IE0002141913.USD","LU1496350502.SGD","LU0640476718.USD","LU2430703095.HKD","LU0787776722.HKD","LU2750360997.AUD","LU1066051225.USD","IE00B3PB1722.GBP","LU0124676726.USD","IE00B42XCP33.USD","LU2347655156.SGD","LU0994945656.USD","LU2468319806.SGD","LU2602419157.SGD","SG9999001440.SGD","LU1674673691.USD","LU0098860793.USD","LU1929549753.HKD","LU2471134796.USD","LU1043141123.HKD","BK4585","LU1244550494.USD","LU0345769128.USD","LU2430703251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141996053","title":"强生宣布Inlexzo永久性医保编码J码正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1141996053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141996053?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:07","pubTimestamp":1775045235,"startTime":"0","endTime":"0","summary":"强生公司近日宣布，其药物Inlexzo的永久性医疗保健通用程序编码系统（HCPCS）J码现已正式生效。该编码的落地将为医疗报销和药品管理提供标准化流程。\n此次永久性J码的获批，标志着Inlexzo在医保支付体系中获得长期认可，有望提升该药物在临床使用中的可及性。医疗供应商现可通过该编码直接进行费用结算，简化了报销流程。\n强生表示，这一进展体现了公司对优化医疗解决方案的持续承诺，也将为患者获得创新治疗方案提供更多便利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4592","LU1162221912.USD","LU0985320562.USD","LU2471134952.CNY","LU2602419157.SGD","LU1244550494.USD","LU0070217475.USD","LU1267930813.SGD","IE00BDGV0183.EUR","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","LU0432979614.USD","LU1778281490.HKD","LU2505996681.GBP","LU1929549753.HKD","LU2471134796.USD","LU2430703178.SGD","IE00BGHQF631.EUR","LU1061106388.HKD","LU0994945656.USD","IE0002270589.USD","LU0426412945.USD","BK4581","LU0203347892.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4568","LU2430703251.USD","LU1023059063.AUD","LU0787776722.HKD","LU0689626769.HKD","LU1221951129.SGD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","IE00B4R5TH58.HKD","LU2129689514.USD","LU1280957306.USD","BK4588","LU1121112475.USD","LU0289739699.SGD","LU2089984988.USD","IE00B3T34201.USD","LU0795875086.SGD","IE0009355771.USD","LU1066051225.USD","BK4532","JNJ","LU1894683348.USD","LU0792757196.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0058720904.USD","IE00BVYPNV92.GBP","LU2129689605.HKD","SG9999001440.SGD","LU1244550577.SGD","LU1914381329.SGD","LU1066051811.HKD","LU0912757837.SGD","IE00BJT1NW94.SGD","LU0426417589.USD","IE00B2B36J28.USD","LU2471134523.USD","IE00BKVL7J92.USD","LU0203345920.USD","LU2750360641.GBP","BK4504","IE00B1BXHZ80.USD","LU2592432038.USD","LU1935042991.SGD","LU0795875169.SGD","LU1261432733.SGD","BK4007","IE00BLSP4452.SGD","LU1066051498.USD","LU1496350502.SGD","LU0882574055.USD","IE00BBT3K403.USD","LU1983299246.USD","LU2347655156.SGD","LU0124676726.USD","LU1506573853.SGD","LU1043141123.HKD","LU1732800096.USD","IE00B19Z3B42.SGD","BK4533","LU0466842654.USD","LU0320765646.SGD","LU1674673691.USD","BK4585","LU1430594728.SGD","LU2750360997.AUD","BK4534","LU1043141396.HKD","LU0234570918.USD","LU1196500208.SGD","IE00B19Z3581.USD","LU1074936037.SGD","LU2430703095.HKD","LU1032955483.USD","SG9999002232.USD","IE00B7SZLL34.SGD","LU1244550221.USD","LU1674673428.USD","LU0345769631.USD","LU0345769128.USD","LU1059921491.USD","LU1732799900.SGD","LU2471134879.HKD","IE00BN8TJ469.HKD","LU0114720955.EUR","LU2133065610.SGD","LU2129689431.USD","LU0098860793.USD","LU1032466523.USD","IE0001KFT4U8.USD","BK4559","LU0640476718.USD","LU1066053197.SGD","LU1894683264.USD","BK4550","LU0345770308.USD","LU0234572021.USD","LU2505996509.AUD","IE00B42XCP33.USD","LU0683600562.USD","LU0889566641.SGD","LU1057294990.SGD","IE00BFXG1179.USD","LU2112291526.USD","IE0034235303.USD","IE00BSNM7G36.USD","LU1718418525.SGD","IE00BVYPNW00.USD","LU1221951046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112955867","title":"强生Icotyde™（Icotrokinra）一年期数据证实：每日一次银屑病口服药可实现持久皮肤清除且安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1112955867","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112955867?lang=zh_cn&edition=full","pubTime":"2026-03-28 22:03","pubTimestamp":1774706596,"startTime":"0","endTime":"0","summary":"强生公司公布的最新一年期临床研究结果显示，其研发的Icotyde™（Icotrokinra）在治疗斑块型银屑病方面展现出持久的皮肤清除效果与良好的安全特性。该每日一次口服疗法在长期用药过程中持续表现出显著疗效，同时维持了可靠的安全性轮廓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2592432038.USD","LU0320765646.SGD","LU0345770308.USD","IE0034235303.USD","IE00B3PB1722.GBP","LU1023059063.AUD","BK4532","LU1244550577.SGD","LU1732799900.SGD","BK4581","LU0792757196.USD","LU2602419157.SGD","LU2505996681.GBP","LU1221951046.USD","SG9999001440.SGD","LU2468319806.SGD","LU1059921491.USD","SG9999002232.USD","LU1066053197.SGD","IE00BDGV0183.EUR","LU1267930813.SGD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","IE00BLSP4452.SGD","LU1732800096.USD","LU2133065610.SGD","LU0985320562.USD","LU1261432733.SGD","LU0640476718.USD","LU0787776722.HKD","LU1894683348.USD","LU2471134952.CNY","IE000M9KFDE8.USD","LU1244550221.USD","BK4504","IE00BGHQF631.EUR","LU2129689431.USD","IE00B1BXHZ80.USD","LU0432979614.USD","LU2750360641.GBP","BK4007","IE00B3T34201.USD","LU0234572021.USD","BK4568","IE00B42XCP33.USD","LU1066051225.USD","LU1196500208.SGD","IE00BN8TJ469.HKD","LU1221951129.SGD","LU0689626769.HKD","JNJ","LU0058720904.USD","LU0889566641.SGD","LU2129689605.HKD","LU0098860793.USD","LU2112291526.USD","LU1066051811.HKD","LU1061106388.HKD","LU0795875086.SGD","LU1718418525.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1074936037.SGD","LU1935042991.SGD","LU0122379950.USD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","LU0466842654.USD","SG9999002224.SGD","LU1244550494.USD","LU1674673428.USD","LU0070217475.USD","BK4559","LU1674673691.USD","LU1032466523.USD","LU1894683264.USD","LU0289739699.SGD","LU1585245621.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE0009355771.USD","LU0234570918.USD","LU0795875169.SGD","LU0345769128.USD","IE0002270589.USD","IE0001KFT4U8.USD","IE00BJT1NW94.SGD","LU2430703178.SGD","LU2347655156.SGD","LU2430703251.USD","BK4550","LU2471134796.USD","LU2505996509.AUD","BK4588","IE00BKVL7J92.USD","BK4592","IE00BBT3K403.USD","LU0124676726.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU1032955483.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU2750360997.AUD","LU2471134879.HKD","LU1983299246.USD","LU0345769631.USD","IE00BVYPNV92.GBP","LU2430703095.HKD","LU1929549753.HKD","LU1778281490.HKD","LU2089984988.USD","BK4533","LU2129689514.USD","LU0683600562.USD","LU0203347892.USD","LU1280957306.USD","IE00BLSP4239.USD","LU1496350502.SGD","LU1430594728.SGD","LU1057294990.SGD","LU0912757837.SGD","IE0002141913.USD","LU1066051498.USD","LU0203345920.USD","BK4534","BK4585","LU1914381329.SGD","LU0345770993.USD","LU2471134523.USD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622732570","title":"股价一年暴涨超700%的Nanobiotix(NBTX.US)迎来收购催化 强生(JNJ.US)有意出手","url":"https://stock-news.laohu8.com/highlight/detail?id=2622732570","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622732570?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:04","pubTimestamp":1774440287,"startTime":"0","endTime":"0","summary":"总部位于巴黎的Nanobiotix与全球医疗保健领军者强生目前保持合作关系，双方根据2023年与这家总部位于新泽西州的制药商强生签署的一项长期许可协议，共同开发并商业化其新一代核心资产JNJ-1900。在刚刚过去的2025年，Nanobiotix股价与市值涨幅已超过700%，使其最新的市值达到约15亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0912757837.SGD","LU1778281490.HKD","LU2430703251.USD","BK4585","IE0001KFT4U8.USD","LU2129689431.USD","IE00BJT1NW94.SGD","JNJ","LU1032955483.USD","LU2471134879.HKD","IE00BZ1G4Q59.USD","IE0009355771.USD","LU1929549753.HKD","LU2471134952.CNY","IE00BVYPNW00.USD","LU1066051811.HKD","LU0234572021.USD","BK4592","IE00B4R5TH58.HKD","LU1244550221.USD","LU1244550577.SGD","LU1718418525.SGD","NBTX","LU0345770993.USD","BK4581","LU2592432038.USD","LU1267930813.SGD","IE00BDGV0183.EUR","BK4139","BK4534","LU1066051225.USD","IE0002141913.USD","IE00B19Z3581.USD","IE00B3PB1722.GBP","IE00BFXG1179.USD","LU0345770308.USD","LU1894683348.USD","SG9999001440.SGD","LU1059921491.USD","LU1732799900.SGD","LU1162221912.USD","LU1061106388.HKD","LU1674673428.USD","LU0787776722.HKD","BK4533","LU2129689514.USD","LU0070217475.USD","IE000M9KFDE8.USD","LU0203345920.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620222625","title":"巴克莱上调强生目标价至234美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620222625","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620222625?lang=zh_cn&edition=full","pubTime":"2026-03-19 23:47","pubTimestamp":1773935221,"startTime":"0","endTime":"0","summary":"巴克莱将强生的目标价从217美元上调至234美元，维持“持股观望”评级。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32082732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620143022","title":"法巴银行：强生新药加入银屑病市场 艾伯维(ABBV.US)王牌药物Skyrizi面临挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=2620143022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620143022?lang=zh_cn&edition=full","pubTime":"2026-03-19 14:55","pubTimestamp":1773903308,"startTime":"0","endTime":"0","summary":"智通财经APP注意到，周三，艾伯维股价下跌超5%，此前法国巴黎银行指出，其免疫学明星药物Skyrizi可能面临来自强生公司与 Protagonist Therapeutics新近获批的斑块状银屑病口服药物Icotyde的竞争。强生与 Protagonist于周三宣布，美国食品药品监督管理局已批准 Icotyde 上市。不过，泰指出，鉴于 Skyrizi 强大的疗效及其每季度一次的注射频率，艾伯维在斑块状银屑病领域仍处于有利地位。泰还提到，针对 Icotyde 在银屑病关节炎等其他炎症性疾病中的持续研究，她认为这“可能代表着对 Skyrizi 的额外竞争”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BGHQF631.EUR","LU0128525929.USD","LU0320765646.SGD","161121","LU1934455277.USD","LU0661504455.SGD","LU0289739699.SGD","LU1267930573.SGD","LU0211327993.USD","LU0345769128.USD","BK4585","LU1935042991.SGD","LU2471134523.USD","LU1983299246.USD","LU1914381329.SGD","LU1244550577.SGD","LU1496350502.SGD","LU0058720904.USD","LU2237443895.HKD","LU0511384066.AUD","SG9999003800.SGD","SG9999015986.USD","LU2750360641.GBP","LU0689626769.HKD","LU0114720955.EUR","LU0122379950.USD","SG9999015952.SGD","LU1074936037.SGD","LU1496350171.SGD","ABBV","BK4566","LU0545039389.USD","IE00BVYPNW00.USD","LU0792757196.USD","LU0795875086.SGD","LU1989772923.USD","IE0009355771.USD","LU1066051811.HKD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","LU1929549753.HKD","JNJ","LU0057025933.USD","LU0158827948.USD","LU1732799900.SGD","LU0795875169.SGD","LU2023251221.USD","LU1267930813.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620259472","title":"强生治疗银屑病的口服药物获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620259472?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:22","pubTimestamp":1773840123,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["JNJ","LU0122379950.USD","BK4007","LU1066051811.HKD","LU2129689514.USD","LU0792757196.USD","LU2468319806.SGD","LU0203347892.USD","LU1894683348.USD","LU2592432038.USD","IE00B4R5TH58.HKD","LU2129689605.HKD","IE00BSNM7G36.USD","LU0234572021.USD","LU1496350502.SGD","LU0114720955.EUR","BK4559","IE00BGHQF631.EUR","LU0689626769.HKD","BK4592","LU2112291526.USD","IE00B1BXHZ80.USD","IE00BVYPNV92.GBP","LABU","IE00BLSP4239.USD","LU2133065610.SGD","LU0203345920.USD","IE00B3T34201.USD","LU2347655156.SGD","IE0002270589.USD","LU1032955483.USD","LU1074936037.SGD","LU0795875169.SGD","LU1244550494.USD","LU1023059063.AUD","IE00B42XCP33.USD","BK4568","BK4581","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1221951129.SGD","LU0912757837.SGD","LU1267930813.SGD","BK4533","LU2471134523.USD","LU2430703095.HKD","IE00B3PB1722.GBP","LU2750360641.GBP","LU0098860793.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124926857","title":"Protagonist股价盘前涨4% 与强生合作口服银屑病药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1124926857","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124926857?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:19","pubTimestamp":1773836390,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了Protagonist Therapeutics与强生公司联合开发的口服银屑病治疗药物，受此消息推动，Protagonist股价在盘前交易中上涨约4%。这一监管批准标志着两家公司在自身免疫疾病治疗领域取得重要突破。银屑病作为一种慢性免疫介导的皮肤病，全球患者人数超过1.25亿，其中中重度患者占比约20%。Protagonist作为一家专注于肽类药物开发的生物技术公司，与制药巨头强生的合作体现了行业内的资源互补模式。除了Protagonist股价上涨外，强生股价也呈现温和上涨态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4592","LU1162221912.USD","LU0985320562.USD","LU2471134952.CNY","LU2602419157.SGD","LU1244550494.USD","LU0070217475.USD","LU1267930813.SGD","IE00BDGV0183.EUR","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","LU0432979614.USD","LU1778281490.HKD","LU2505996681.GBP","LU1929549753.HKD","LU2471134796.USD","LU2430703178.SGD","IE00BGHQF631.EUR","LU1061106388.HKD","IE0002270589.USD","BK4581","LU0203347892.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4568","LU2430703251.USD","LU1023059063.AUD","LU0787776722.HKD","LU0689626769.HKD","LU1221951129.SGD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","IE00B4R5TH58.HKD","LU2129689514.USD","LU1280957306.USD","BK4588","LU0289739699.SGD","LU2089984988.USD","IE00B3T34201.USD","LU0795875086.SGD","IE0009355771.USD","LU1066051225.USD","BK4139","BK4532","JNJ","LU1894683348.USD","LU0792757196.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0058720904.USD","IE00BVYPNV92.GBP","LU2129689605.HKD","SG9999001440.SGD","LU1244550577.SGD","LU1914381329.SGD","LU1066051811.HKD","LU0912757837.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU2471134523.USD","IE00BKVL7J92.USD","LU0203345920.USD","LU2750360641.GBP","BK4504","IE00B1BXHZ80.USD","LU2592432038.USD","LU1935042991.SGD","LU0795875169.SGD","LU1261432733.SGD","BK4007","IE00BLSP4452.SGD","LU1066051498.USD","LU1496350502.SGD","LU0882574055.USD","IE00BBT3K403.USD","LU1983299246.USD","LU2347655156.SGD","LU0124676726.USD","LU1506573853.SGD","LU1732800096.USD","IE00B19Z3B42.SGD","BK4533","LU0466842654.USD","LU0320765646.SGD","LU1674673691.USD","BK4585","LU1430594728.SGD","LU2750360997.AUD","BK4534","LU0234570918.USD","LU1196500208.SGD","IE00B19Z3581.USD","LU1074936037.SGD","LU2430703095.HKD","LU1032955483.USD","SG9999002232.USD","IE00B7SZLL34.SGD","LU1244550221.USD","LU1674673428.USD","LU0345769631.USD","PTGX","LU0345769128.USD","LU1059921491.USD","LU1732799900.SGD","LU2471134879.HKD","IE00BN8TJ469.HKD","LU0114720955.EUR","LU2133065610.SGD","LU2129689431.USD","LU0098860793.USD","LU1032466523.USD","IE0001KFT4U8.USD","BK4559","LU0640476718.USD","LU1066053197.SGD","LU1894683264.USD","BK4550","LU0345770308.USD","LU0234572021.USD","LU2505996509.AUD","IE00B42XCP33.USD","LU0683600562.USD","LU0889566641.SGD","LU1057294990.SGD","IE00BFXG1179.USD","LU2112291526.USD","IE0034235303.USD","IE00BSNM7G36.USD","LU1718418525.SGD","IE00BVYPNW00.USD","LU1221951046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121159608","title":"强生Icotyde安全性数据亮眼：16周不良反应率与安慰剂差异仅1.1%，52周无新风险信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1121159608","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121159608?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:52","pubTimestamp":1773834742,"startTime":"0","endTime":"0","summary":"强生公司旗下药物Icotyde在最新临床试验中展现出优异的安全性特征。数据显示，截至治疗第16周，Icotyde组患者的不良反应发生率与安慰剂组差异控制在1.1个百分点以内，显示出与安慰剂相近的短期耐受性。更值得注意的是，在延长观察至第52周后，研究未发现新的安全性风险信号，进一步巩固了该药物的长期用药安全基础。强生此次披露的52周长期安全性结果，为Icotyde在同类药物中建立了差异化优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0882574055.USD","LU0912757837.SGD","LU1244550577.SGD","LU2471134523.USD","LU1162221912.USD","LU1023059063.AUD","IE00BKVL7J92.USD","LU0203347892.USD","LU2471134796.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU2471134952.CNY","IE00B42XCP33.USD","LU0234570918.USD","LU1674673428.USD","LU2505996681.GBP","LU1057294990.SGD","LU0985320562.USD","BK4568","SG9999001440.SGD","LU2112291526.USD","LU1983299246.USD","LU1032955483.USD","LU1718418525.SGD","LU0795875169.SGD","LU1732799900.SGD","LU1430594728.SGD","IE00BLSP4452.SGD","LU2129689514.USD","LU1506573853.SGD","LU2089984988.USD","LU2133065610.SGD","LU0058720904.USD","LU2129689605.HKD","LU1074936037.SGD","LU0345769631.USD","LU1066051498.USD","LU2750360641.GBP","LU2750360997.AUD","LU0432979614.USD","IE00BVYPNV92.GBP","LU0640476718.USD","IE00BGHQF631.EUR","LU1221951046.USD","BK4559","LU1261432733.SGD","BK4007","SG9999002232.USD","LU1929549753.HKD","LU1196500208.SGD","LU0289739699.SGD","LU2468319806.SGD","LU1280957306.USD","LU2129689431.USD","LU1059921491.USD","BK4581","BK4533","LU0795875086.SGD","IE00BJT1NW94.SGD","LU1674673691.USD","LU0345769128.USD","BK4534","JNJ","LU0345770993.USD","BK4504","LU2602419157.SGD","LU1585245621.USD","IE00BDGV0183.EUR","IE00BFXG1179.USD","IE00BLSP4239.USD","LU0320765646.SGD","LU1066051225.USD","IE000M9KFDE8.USD","LU2430703095.HKD","LU0114720955.EUR","IE00B7SZLL34.SGD","IE00B3PB1722.GBP","IE00BJJMRZ35.SGD","LU0787776722.HKD","LU2430703178.SGD","LU0070217475.USD","IE0002141913.USD","LU0466842654.USD","LU1778281490.HKD","IE0034235303.USD","LU1244550221.USD","BK4532","LU2430703251.USD","LU2347655156.SGD","IE00BVYPNW00.USD","IE00BBT3K403.USD","LU0889566641.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU1914381329.SGD","IE00B1BXHZ80.USD","IE0002270589.USD","LU0098860793.USD","LU1267930813.SGD","LU1032466523.USD","IE00B3T34201.USD","LU2505996509.AUD","IE00BN8TJ469.HKD","IE00BZ1G4Q59.USD","LU1244550494.USD","LU1894683264.USD","BK4550","LU0203345920.USD","IE00BSNM7G36.USD","LU0124676726.USD","LU2471134879.HKD","IE00B4R5TH58.HKD","IE0001KFT4U8.USD","SG9999002224.SGD","LU0345770308.USD","IE0009355771.USD","LU1935042991.SGD","LU1732800096.USD","LU1061106388.HKD","LU2592432038.USD","IE00B19Z3581.USD","LU0683600562.USD","BK4585","LU0122379950.USD","LU1066051811.HKD","LU0689626769.HKD","LU1496350502.SGD","LU1894683348.USD","LU1221951129.SGD","LU0234572021.USD","LU0792757196.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140410513","title":"FDA批准Icotyde™开创银屑病口服靶向疗法新时代 强生领跑千亿市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1140410513","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140410513?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:51","pubTimestamp":1773834696,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准Icotyde用于斑块状银屑病的一线系统治疗。该药物是全球首款针对该适应症的口服靶向肽类药物，标志着银屑病治疗从生物制剂注射向口服靶向疗法的重大转变。Icotyde的获批将直接冲击现有市场规模达240亿美元的银屑病治疗领域，特别是对需要长期用药的轻中度患者群体具有显著吸引力。同时，传统银屑病生物制剂厂商可能面临定价压力，需要重新评估市场策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE000M9KFDE8.USD","LU1430594728.SGD","BK4504","LU1221951046.USD","LU1261432733.SGD","LU0234572021.USD","LU0683600562.USD","LU1066051811.HKD","LU1983299246.USD","LU2471134879.HKD","BK4534","LU1244550494.USD","LU1032466523.USD","LU2468319806.SGD","LU0345769631.USD","LU1059921491.USD","LU0203347892.USD","IE00B19Z3B42.SGD","LU2430703178.SGD","IE00BLSP4452.SGD","LU1914381329.SGD","LU0114720955.EUR","IE00BBT3K403.USD","LU1074936037.SGD","IE00B3PB1722.GBP","LU2129689514.USD","LU1061106388.HKD","LU2592432038.USD","LU1732799900.SGD","LU0124676726.USD","LU2471134952.CNY","LU0122379950.USD","IE00B1BXHZ80.USD","LU1066051498.USD","BK4532","LU0289739699.SGD","LU1066051225.USD","IE00BFTCPJ56.SGD","LU2602419157.SGD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU0203345920.USD","LU1196500208.SGD","BK4588","LU1894683264.USD","IE00BVYPNV92.GBP","IE00BLSP4239.USD","SG9999002232.USD","LU2347655156.SGD","LU0345769128.USD","LU0466842654.USD","LU1162221912.USD","JNJ","LU0795875169.SGD","IE0034235303.USD","IE00BDGV0183.EUR","LU0432979614.USD","LU0070217475.USD","BK4007","LU2430703095.HKD","LU1057294990.SGD","IE0001KFT4U8.USD","IE00B19Z3581.USD","LU2112291526.USD","LU1023059063.AUD","LU0234570918.USD","IE00B3T34201.USD","LU2750360997.AUD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4568","BK4550","LU1280957306.USD","LU1894683348.USD","LU2505996681.GBP","LU0640476718.USD","IE0002141913.USD","LU0912757837.SGD","LU0098860793.USD","BK4559","LU1778281490.HKD","LU2129689605.HKD","LU1066053197.SGD","LU1506573853.SGD","LU2430703251.USD","LU0985320562.USD","LU1032955483.USD","LU0787776722.HKD","LU2133065610.SGD","IE00BFXG1179.USD","BK4581","LU2089984988.USD","LU1221951129.SGD","IE00B42XCP33.USD","LU1929549753.HKD","IE00BJJMRZ35.SGD","BK4533","LU0320765646.SGD","SG9999002224.SGD","IE00BZ1G4Q59.USD","BK4585","BK4592","IE00B4R5TH58.HKD","LU0345770308.USD","LU0689626769.HKD","LU1718418525.SGD","IE0002270589.USD","SG9999001440.SGD","IE00BSNM7G36.USD","IE0009355771.USD","LU0889566641.SGD","LU1674673428.USD","LU1732800096.USD","LU2129689431.USD","LU1244550577.SGD","LU2471134796.USD","LU0795875086.SGD","LU2471134523.USD","LU0792757196.USD","LU1585245621.USD","LU2750360641.GBP","IE00BKVL7J92.USD","LU2505996509.AUD","LU1244550221.USD","LU1496350502.SGD","LU1935042991.SGD","LU1267930813.SGD","IE00BN8TJ469.HKD","LU1674673691.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193972176","title":"Monte Rosa Therapeutics宣布临床供应协议 支持MRT-2359联合阿帕鲁胺治疗转移性去势抵抗性前列腺癌的二期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1193972176","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193972176?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:54","pubTimestamp":1773662077,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics公司宣布达成一项临床供应协议，旨在支持评估MRT-2359联合阿帕鲁胺治疗转移性去势抵抗性前列腺癌的二期临床试验。\n根据协议，Monte Rosa Therapeutics计划于2026年第三季度启动MRT-2359与阿帕UTAMIDE的二期研究。该公司已与强生公司签署供应协议，为这项定于2026年第三季度开始的转移性去势抵抗性前列腺癌二期研究提供支持。\nMonte Rosa Therapeutics将负责开展并资助该试验；强生公司将供应其药物阿帕鲁胺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1221951046.USD","IE00BJT1NW94.SGD","LU1066051498.USD","SG9999002224.SGD","BK4539","LU1267930813.SGD","BK4585","BK4550","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU0640476718.USD","IE00B3PB1722.GBP","IE00BBT3K403.USD","LU2129689431.USD","LU0345769631.USD","LU2602419157.SGD","LU1244550221.USD","LU0345770308.USD","LU1430594728.SGD","LU1778281490.HKD","LU1032955483.USD","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1496350502.SGD","LU0058720904.USD","LU1894683348.USD","LU1935042991.SGD","LU1066053197.SGD","SG9999002232.USD","LU0787776722.HKD","LU2129689514.USD","IE00BDGV0183.EUR","IE0034235303.USD","LU2112291526.USD","LU2750360641.GBP","IE00BN8TJ469.HKD","LU0792757196.USD","IE00BGHQF631.EUR","IE0001KFT4U8.USD","LU0795875169.SGD","IE00B42XCP33.USD","LU2592432038.USD","LU0345769128.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU1244550494.USD","IE00BJJMRZ35.SGD","BK4568","IE00BVYPNV92.GBP","LU1585245621.USD","BK4581","LU0203347892.USD","LU1074936037.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0114720955.EUR","IE00BFXG1179.USD","LU0795875086.SGD","GLUE","IE00B19Z3581.USD","LU0689626769.HKD","LU2505996509.AUD","BK4504","LU0124676726.USD","LU0466842654.USD","LU1261432733.SGD","BK4559","LU0683600562.USD","LU2750360997.AUD","LU1732800096.USD","LU0345770993.USD","LU1894683264.USD","LU2471134879.HKD","SG9999001440.SGD","LU1674673691.USD","LU1280957306.USD","IE000M9KFDE8.USD","LU0432979614.USD","LU2471134952.CNY","LU1066051811.HKD","LU0985320562.USD","LU2471134523.USD","LU1032466523.USD","BK4534","IE00B4R5TH58.HKD","IE0002141913.USD","LU0098860793.USD","IE00BVYPNW00.USD","BK4007","BK4533","IE0009355771.USD","LU1506573853.SGD","LU0882574055.USD","LU1244550577.SGD","LU0912757837.SGD","LU0320765646.SGD","JNJ","LU1162221912.USD","LU2089984988.USD","LU1221951129.SGD","LU1983299246.USD","LU0203345920.USD","LU2129689605.HKD","LU2430703251.USD","LU1023059063.AUD","LU0234570918.USD","IE00B7SZLL34.SGD","BK4532","BK4592","LU1061106388.HKD","LU1718418525.SGD","IE0002270589.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU0122379950.USD","LU2430703095.HKD","LU1914381329.SGD","LU2430703178.SGD","LU1732799900.SGD","IE00BLSP4452.SGD","IE00BZ1G4Q59.USD","LU0234572021.USD","LU0889566641.SGD","LU1059921491.USD","LU1929549753.HKD","LU1674673428.USD","LU1066051225.USD","LU2133065610.SGD","LU2505996681.GBP","BK4588","LU2471134796.USD","LU2347655156.SGD","IE00B1BXHZ80.USD","LU0070217475.USD","LU1196500208.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618182691","title":"花旗上调强生目标价至274美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618182691","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618182691?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:01","pubTimestamp":1773306114,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0070217475.USD","IE00BLSP4239.USD","LU0345770993.USD","LU1267930813.SGD","LU1506573853.SGD","LU1261432733.SGD","LU0203345920.USD","LU0345769631.USD","LU2089984988.USD","IE00BDGV0183.EUR","LU0098860793.USD","IE0034235303.USD","LU0640476718.USD","JNJ","LU1430594728.SGD","IE00B2B36J28.USD","LU0912757837.SGD","LU0314106906.USD","BK4559","IE000M9KFDE8.USD","IE0001KFT4U8.USD","LU0203347892.USD","LU2129689514.USD","IE00BBT3K403.USD","BK4585","BK4568","LU1668664300.SGD","BK4550","BK4534","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2417539215.USD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","LU0889566641.SGD","LU1732800096.USD","IE0009355771.USD","LU1983299246.USD","LU1066051225.USD","LU1585245621.USD","LU2430703251.USD","LU1718418525.SGD","BK4581","LU2236285917.USD","LU2505996509.AUD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0162691827.USD","IE00B3PB1722.GBP","LU0345769128.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126952419","title":"Tecvayli®▼ (Teclistamab)单药疗法申请提交至欧洲药品管理局，用于治疗至少接受过一种前期疗法的复发/难治性多发性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1126952419","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126952419?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:57","pubTimestamp":1773143831,"startTime":"0","endTime":"0","summary":"强生公司已向欧洲药品管理局（EMA）提交了Tecvayli®▼ (Teclistamab)作为单药疗法的上市许可申请。该申请旨在寻求批准该药物用于治疗那些至少接受过一种前期疗法后仍出现复发或难治性的多发性骨髓瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU1061106388.HKD","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU1929549753.HKD","LU0289739699.SGD","LU1074936037.SGD","IE00BJT1NW94.SGD","BK4559","LU1057294990.SGD","LU1778281490.HKD","LU1894683264.USD","LU2430703095.HKD","IE0001KFT4U8.USD","LU2471134796.USD","IE00BZ1G4Q59.USD","LU1059921491.USD","BK4550","LU0985320562.USD","IE00BJJMRZ35.SGD","BK4533","IE00BSNM7G36.USD","BK4504","LU2602419157.SGD","IE00B3T34201.USD","IE0002141913.USD","IE0009355771.USD","LU2133065610.SGD","LU1032466523.USD","IE00BVYPNV92.GBP","LU1196500208.SGD","LU1066051811.HKD","LU0345769631.USD","LU2129689431.USD","IE00BLSP4239.USD","LU1267930813.SGD","LU1261432733.SGD","LU0203345920.USD","LU0234572021.USD","IE0034235303.USD","LU1496350502.SGD","LU0640476718.USD","LU1244550577.SGD","JNJ","IE00BLSP4452.SGD","LU1430594728.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU0114720955.EUR","LU2750360997.AUD","LU2129689514.USD","LU2129689605.HKD","IE00BBT3K403.USD","LU1674673691.USD","LU0345769128.USD","BK4534","LU0795875169.SGD","LU1221951129.SGD","LU0889566641.SGD","SG9999002232.USD","LU0320765646.SGD","LU1244550221.USD","LU2430703251.USD","LU2750360641.GBP","LU0124676726.USD","BK4581","LU1066051225.USD","LU0070217475.USD","LU1935042991.SGD","LU2471134879.HKD","LU0345770308.USD","LU0345770993.USD","IE00BFXG1179.USD","LU1506573853.SGD","LU1032955483.USD","LU0098860793.USD","LU0234570918.USD","BK4532","LU0683600562.USD","BK4588","LU1066051498.USD","LU1066053197.SGD","LU0689626769.HKD","LU1244550494.USD","LU0792757196.USD","LU2592432038.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","IE00B19Z3B42.SGD","SG9999001440.SGD","LU2468319806.SGD","BK4007","LU1732799900.SGD","IE00BVYPNW00.USD","IE00B19Z3581.USD","IE0002270589.USD","LU1585245621.USD","LU2430703178.SGD","LU2112291526.USD","IE00BKVL7J92.USD","LU1718418525.SGD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","LU2471134523.USD","LU1674673428.USD","IE00B3PB1722.GBP","BK4592","LU0122379950.USD","LU1914381329.SGD","LU0787776722.HKD","LU1280957306.USD","LU2089984988.USD","LU1162221912.USD","LU2505996681.GBP","LU2471134952.CNY","LU0912757837.SGD","IE000M9KFDE8.USD","IE00B7SZLL34.SGD","LU0203347892.USD","BK4585","LU0432979614.USD","LU0795875086.SGD","BK4568","LU1894683348.USD","LU0882574055.USD","LU1221951046.USD","IE00BN8TJ469.HKD","LU1732800096.USD","LU1983299246.USD","SG9999002224.SGD","LU2505996509.AUD","LU0058720904.USD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617631379","title":"强生多发性骨髓瘤组合疗法获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631379","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617631379?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:08","pubTimestamp":1772806080,"startTime":"0","endTime":"0","summary":"美国食品与药品管理局（FDA）周五表示，在III期数据显示出显著的无进展生存期和总生存期获益后，强生的TECVAYLI联合DARZALEX FASPRO方案获得批准，用于治疗复发/难治性多发性骨髓瘤。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-06/doc-inhqahae2470435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1061106388.HKD","LU1221951129.SGD","LU1732799900.SGD","IE00B42XCP33.USD","LU1929549753.HKD","LU0122379950.USD","BK4533","IE00B1BXHZ80.USD","LU1430594728.SGD","BK4504","IE00B19Z3581.USD","BK4532","LU0289739699.SGD","LU1221951046.USD","IE00B4R5TH58.HKD","BK4585","LU1066051225.USD","LU2112291526.USD","LU1718418525.SGD","LU1023059063.AUD","SG9999001440.SGD","LU2750360997.AUD","LU0889566641.SGD","LU0683600562.USD","BK4588","LU1066051811.HKD","LU1674673428.USD","LU2129689431.USD","BK4568","BK4550","LU1280957306.USD","LU0792757196.USD","LU1894683348.USD","LU2505996681.GBP","LU1244550494.USD","LU1032466523.USD","IE0002141913.USD","LU0345769128.USD","LU1244550221.USD","LU0466842654.USD","LU1267930813.SGD","LU2430703178.SGD","IE00BN8TJ469.HKD","JNJ","IE00BBT3K403.USD","LU1032955483.USD","LU2129689514.USD","LU0787776722.HKD","BK4581","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617881646","title":"小摩上调强生目标价至250美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617881646","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617881646?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:06","pubTimestamp":1772784402,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1032466523.USD","LU1066051225.USD","BK4592","LU2129689514.USD","LU1196500208.SGD","BK4533","LU0234572021.USD","LU2129689605.HKD","BK4588","IE00B3T34201.USD","LU1066053197.SGD","LU1674673691.USD","LU2089984988.USD","LU2471134523.USD","LU1057294990.SGD","LU1914381329.SGD","LU1244550577.SGD","LU0058720904.USD","IE00B7SZLL34.SGD","IE00BJT1NW94.SGD","LU0203345920.USD","LU2347655156.SGD","LU0689626769.HKD","LU1732800096.USD","LU1162221912.USD","LU0122379950.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK4534","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1506573853.SGD","LU1059921491.USD","LU2430703251.USD","LU0345769631.USD","LU1066051811.HKD","IE0034235303.USD","LU2592432038.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1929549753.HKD","LU0345770308.USD","LU2112291526.USD","JNJ","LU2471134952.CNY","LU0234570918.USD","LU2750360997.AUD","IE00BLSP4239.USD","LU1280957306.USD","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189059267","title":"强生宣布Tecvayli®联合Darzalex Faspro®获美国FDA批准，用于复发/难治性多发性骨髓瘤，有望在二线治疗中树立新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1189059267","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189059267?lang=zh_cn&edition=full","pubTime":"2026-03-06 04:56","pubTimestamp":1772744173,"startTime":"0","endTime":"0","summary":"强生公司宣布，其Tecvayli®联合Darzalex Faspro®的治疗方案已获得美国食品药品监督管理局（FDA）的批准，用于治疗复发或难治性多发性骨髓瘤患者。\n这一批准意义重大，因为它为患者提供了一种潜在的全新护理标准，该方案甚至可在疾病的第二线治疗阶段就尽早使用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU1162221912.USD","IE0009355771.USD","LU1196500208.SGD","SG9999001440.SGD","LU1732799900.SGD","IE0002270589.USD","IE0001KFT4U8.USD","LU1935042991.SGD","LU0122379950.USD","IE00BFXG1179.USD","LU0234570918.USD","LU1674673428.USD","BK4588","LU0689626769.HKD","LU1778281490.HKD","LU2471134952.CNY","BK4568","LU1066051225.USD","LU2750360641.GBP","LU0234572021.USD","LU2602419157.SGD","LU0432979614.USD","LU1057294990.SGD","LU0124676726.USD","LU0070217475.USD","LU0882574055.USD","LU2505996681.GBP","LU1506573853.SGD","LU0683600562.USD","LU0114720955.EUR","LU1066051811.HKD","IE00BSNM7G36.USD","BK4533","IE00BBT3K403.USD","LU2430703095.HKD","LU0792757196.USD","LU1074936037.SGD","LU1244550577.SGD","LU2347655156.SGD","LU1674673691.USD","BK4007","LU2468319806.SGD","LU2129689514.USD","LU0795875169.SGD","LU2133065610.SGD","BK4559","IE00B3T34201.USD","LU1585245621.USD","LU0466842654.USD","LU0345769631.USD","LU0098860793.USD","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","BK4532","LU2430703178.SGD","LU1894683348.USD","LU2129689431.USD","LU2089984988.USD","IE00BVYPNW00.USD","LU2471134523.USD","BK4504","LU1221951129.SGD","LU2750360997.AUD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1732800096.USD","IE0002141913.USD","BK4534","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","IE00BKVL7J92.USD","IE00B42XCP33.USD","SG9999002232.USD","LU0889566641.SGD","LU2471134796.USD","BK4581","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","LU1914381329.SGD","LU1929549753.HKD","LU1059921491.USD","IE00B4R5TH58.HKD","LU1244550221.USD","LU1718418525.SGD","IE00BLSP4452.SGD","BK4592","LU1032466523.USD","LU1261432733.SGD","IE00BVYPNV92.GBP","LU0203345920.USD","IE00B2B36J28.USD","LU2505996509.AUD","IE00B3PB1722.GBP","LU1032955483.USD","LU2112291526.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU0345770993.USD","LU1221951046.USD","LU1244550494.USD","IE00B1BXHZ80.USD","BK4550","LU1066053197.SGD","LU0985320562.USD","BK4585","LU1061106388.HKD","LU2471134879.HKD","LU0912757837.SGD","LU1983299246.USD","LU1280957306.USD","LU0289739699.SGD","LU2129689605.HKD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0787776722.HKD","IE00B7SZLL34.SGD","LU1430594728.SGD","IE0034235303.USD","LU0320765646.SGD","LU0345769128.USD","LU2592432038.USD","LU1066051498.USD","LU0345770308.USD","LU0795875086.SGD","LU0203347892.USD","LU1267930813.SGD","LU1894683264.USD","LU2430703251.USD","LU1496350502.SGD","IE00BDGV0183.EUR","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617687025","title":"强生猛将，空降默沙东！","url":"https://stock-news.laohu8.com/highlight/detail?id=2617687025","media":"张通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617687025?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:43","pubTimestamp":1772621012,"startTime":"0","endTime":"0","summary":"张通社 zhangtongshe.com｜源于张江、立足上海、服务科创｜近日，据业内消息，默沙东中国正式官宣重磅人事变动：任命强生创新制药前免疫治疗事业部负责人潘昉玥出任新设立的肿瘤事业部负责人。根据默沙东2月26日官宣，范柏睿将出任印度总经理，3月1日正式履职，新岗位直接向亚太区总裁汇报并进入亚太领导团队。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304185332a6a1dd43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304185332a6a1dd43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","SG9999014542.SGD","IE00BLSP4239.USD","LU2347655156.SGD","LU2361045086.USD","LU1037948897.HKD","SG9999015358.SGD","LU0203345920.USD","LU2361044865.SGD","LU0006306889.USD","LU2471134796.USD","IE00BFXG1179.USD","LU0648001328.SGD","SG9999001176.SGD","LU0211331839.USD","LU1221951129.SGD","LU2106854487.HKD","LU1066051811.HKD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0238689110.USD","IE00BZ1G4Q59.USD","LU2505996681.GBP","LU2430703251.USD","LU0965509283.SGD","SG9999014567.USD","BK4588","LU2125154778.USD","LU2750360997.AUD","LU1074936037.SGD","SG9999001176.USD","LU0114720955.EUR","LU2360032135.SGD","IE00BSNM7G36.USD","LU1221951046.USD","LU1066051225.USD","LU2471134952.CNY","LU0058720904.USD","IE00B3PB1722.GBP","BK4007","IE00BVYPNV92.GBP","IE0009355771.USD","LU1093756325.SGD","LU2430703178.SGD","LU1934455277.USD","LU1989772840.SGD","LU1059921491.USD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU1935042991.SGD","BK4592","LU0787776722.HKD","IE00B19Z3B42.SGD","LU1894683348.USD","LU2324357040.USD","LU2129689605.HKD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BGHQF631.EUR","LU1506573853.SGD","LU2089984988.USD","LU0265550359.USD","SG9999015341.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","LU2023250843.SGD","SG9999014575.USD","LU1989772923.USD","JNJ","MRK","LU2602419157.SGD","IE0002141913.USD","IE00BBT3K403.USD","LU1196500208.SGD","IE0034235303.USD","LU2133065610.SGD","LU0266013472.USD","IE00B19Z3581.USD","LU0466842654.USD","LU0889566641.SGD","BK4534","LU1267930813.SGD","LU1732799900.SGD","LU0106261372.USD","IE00BDGV0183.EUR","LU1934455194.USD","LU2592432038.USD","LU1061106388.HKD","BK4559","LU1291159041.SGD","LU0320765489.SGD","BK4533","LU0965508806.USD","LU0070302665.USD","LU1941712264.USD","LU1989771016.USD","LU0345769128.USD","LU0942090050.USD","LU1674673428.USD","LU2430703095.HKD","LU0985320562.USD","LU0965509010.AUD","LU1035773651.USD","LU1261432733.SGD","LU0912757837.SGD","BK4581","SG9999001440.SGD","IE00B2B36J28.USD","LU1732800096.USD","BK4532","IE00B1BXHZ80.USD","LU0640476718.USD","LU1069347547.HKD","IE00B42XCP33.USD","LU1571399168.USD","LU0098860793.USD","LU0795875086.SGD","BK4516","LU1674673691.USD","LU1093756168.USD","IE000M9KFDE8.USD","LU1914381329.SGD","LU0208291251.USD","LU2125154935.USD","BK4550","LU0124676726.USD","LU0868494708.USD","SG9999013999.USD","LU1585245621.USD","LU2505996509.AUD","LU0130517989.USD","LU0795875169.SGD","LU1941712348.USD","SG9999014559.SGD","IE00BVYPNW00.USD","LU1929549753.HKD","LU0965509101.SGD","IE00BLSP4452.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1032466523.USD","LU0203347892.USD","LU1037948541.HKD","LU1116320901.HKD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0289739699.SGD","LU1032955483.USD","LU0130102774.USD","BK4568","IE0001KFT4U8.USD","BK4504","LU1066053197.SGD","LU1280957306.USD","LU1430594728.SGD","LU0689626769.HKD","LU0345769631.USD","LU2750360641.GBP","LU2471134879.HKD","LU0432979614.USD","LU1116320737.USD","LU2023250504.SGD","LU0980610538.SGD","LU0477156953.USD","SG9999002224.SGD","LU1244550577.SGD","LU0265550946.USD","SGXZ57979304.SGD","IE00B3T34201.USD","LU0792757196.USD","LU2468319806.SGD","LU0345770308.USD","LU1201861249.SGD","LU0683600562.USD","LU0861579265.USD","LU2361044949.HKD","LU1917777945.USD","LU1894683264.USD","IE0002270589.USD","LU1244550221.USD","LU1496350502.SGD","LU2129689514.USD","LU2461242641.AUD","LU1974910355.USD","LU2129689431.USD","LU1983299246.USD","SG9999002232.USD","LU2471134523.USD","LU0122379950.USD","LU1934455863.HKD","LU1066051498.USD","LU2112291526.USD","LU1162221912.USD","LU1244550494.USD","IE00BN8TJ469.HKD","LU0070217475.USD","LU1699723380.USD","LU0345770993.USD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":-0.0186},{"period":"3month","weight":0.1667},{"period":"6month","weight":0.2503},{"period":"1year","weight":0.6037},{"period":"ytd","weight":0.1523}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015928},{"month":4,"riseRate":0.617021,"avgChangeRate":0.031172},{"month":5,"riseRate":0.478261,"avgChangeRate":-0.025904},{"month":6,"riseRate":0.5,"avgChangeRate":0.005615},{"month":7,"riseRate":0.608696,"avgChangeRate":0.013965},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}